Biogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s rulingBiogen has downbeat news about its gene therapy for the rare inherited eye disease, X-linked retinitis pigmentosa, announcing Share XBiogen’s eye disease gene therapy fails ahead of FDA Alzheimer’s rulinghttps://pharmaphorum.com/news/biogens-eye-disease-gene-therapy-fails-ahead-of-fda-alzheimers-ruling/
